Amyloidosis
Showing 751 - 760 of 760
Renal Dialysis Trial in Melbourne (Larger pore haemodialysis membrane, Standard haemodialysis membrane)
Completed
- Renal Dialysis
- Larger pore haemodialysis membrane
- Standard haemodialysis membrane
-
Melbourne, Victoria, AustraliaAustin Health
Jul 6, 2009
Amyloidosis Trial in New York (Melphalan, Autologous Stem Cell Transplantation)
Completed
- Amyloidosis
- Melphalan
- Autologous Stem Cell Transplantation
-
New York, New YorkHerbert Irving Comprehensive Cancer Center
Jun 6, 2008
Amyloidosis & Heart Failure Being Evaluated forHeart Transplant
Completed
- Cardiomyopathy
- (no location specified)
Apr 3, 2007
Coronary Artery Disease, Inflammatory Response, Atherosclerosis Trial in Willoughby Hills (eicosapentaenoic acid (EPA),)
Terminated
- Coronary Artery Disease
- +2 more
- eicosapentaenoic acid (EPA),
-
Willoughby Hills, OhioCleveland Clinic Willoughby Hills Family Health Center
Dec 19, 2007
Autoinflammatory Syndromes, HIDS, TRAPS Trial in Nijmegen (ITF2357)
Unknown status
- Autoinflammatory Syndromes
- +3 more
-
Nijmegen, NetherlandsRadboud University Medical Centre Nijmegen
Feb 28, 2007
Secondary (AA) Amyloidosis, Rheumatoid Arthritis, Nephrotic Syndrome Trial in Worldwide (NC-503 (Anti-amyloidotic (AA) Agent))
Completed
- Secondary (AA) Amyloidosis
- +5 more
- NC-503 (Anti-amyloidotic (AA) Agent)
-
Indianapolis, Indiana
- +25 more
Feb 13, 2006
Study of Systemic Amyloidosis Presentation and Prognosis
Unknown status
- Amyloidosis
-
Indianapolis, IndianaIndiana University Cancer Center
Jun 23, 2005
Monoclonal Immunoglobulins in Patient With Tuberculosis
Unknown status
- Monoclonal Gammopathy
- Tuberculosis
-
Taipei, TaiwanDepartment of Laboratory Medicine, National Taiwan Univeristy Ho
Sep 12, 2005